Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 25 of 25 results for familial breast cancer

  1. Artificial intelligence in mammography (MIB242)

    NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography .

    Medtech innovation briefing
    Published
    5 January 2021

  2. Board, executive team and senior leaders interests register

    long-term conditions (non-remunerated)Co-chair, NHS England Cholesterol and Familial Hypercholesterolaemia Expert Advisory Group...

  3. Board, executive team and senior leaders interests register

    long-term conditions (non-remunerated)Co-chair, NHS England Cholesterol and Familial Hypercholesterolaemia Expert Advisory Group...

  4. Board, executive team and senior leaders interests register

    long-term conditions (non-remunerated)Co-chair, NHS England Cholesterol and Familial Hypercholesterolaemia Expert Advisory Group...

  5. NICE and health inequalities

    Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged

  6. Familial breast cancer (CG41)

    This guidance has been updated and replaced by NICE guideline CG164.

    Clinical guideline
    Published
    25 October 2006

  7. Familial breast cancer (CG14)

    This guidance has been updated and replaced by NICE guideline CG41.

    Clinical guideline
    Published
    23 May 2004

  8. Suspected neurological conditions: recognition and referral (NG127)

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

    NICE guideline
    Last updated
    2 October 2023

    Sections for NG127

  9. Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)

    Evidence-based recommendations on using immunohistochemistry or microsatellite instability testing to guide further testing for Lynch syndrome in people with colorectal cancer

    Diagnostics guidance
    Published
    22 February 2017
    View recommendations

    Sections for DG27

  10. Breast cancer (QS12)

    This quality standard covers the care of people with breast cancer after they have been referred to a specialist team. It includes the management of early (ductal carcinoma in situ and invasive), locally advanced and advanced breast cancer; recurrent breast cancer; and familial breast cancer. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    16 June 2016
    View quality statements

    Sections for QS12